Letter to the editor: Response to Giardiello D, Antoniou AC, Mariani L, Easton DF, Steyerberg EW

by Chang Ming, Valeria Viassolo, Nicole Probst-Hensch, Pierre O. Chappuis, Ivo D. Dinov, Maria C. Katapodi
Published 2020-04-01

Machine learning techniques for personalized breast cancer risk prediction: comparison with the BCRAT and BOADICEA models

by Chang Ming, Valeria Viassolo, Nicole Probst-Hensch, Pierre O. Chappuis, Ivo D. Dinov, Maria C. Katapodi
Published 2019-06-01

Physicians communicating with women at genetic risk of breast and ovarian cancer: Are we in the middle of the ford between contradictory messages and unshared decision making?

by Marta Fadda, Pierre O Chappuis, Maria C Katapodi, Olivia Pagani, Christian Monnerat, Véronique Membrez, Sheila Unger, Maria Caiata Zufferey, Maria Caiata Zufferey
Published 2020-01-01

A new bioinformatics tool to help assess the significance of BRCA1 variants

by Isabelle Cusin, Daniel Teixeira, Monique Zahn-Zabal, Valentine Rech de Laval, Anne Gleizes, Valeria Viassolo, Pierre O. Chappuis, Pierre Hutter, Amos Bairoch, Pascale Gaudet
Published 2018-07-01

Ovarian cancer with high-level focal ERBB2 amplification responds to trastuzumab and pertuzumab

by Laure Thouvenin, Mélinda Charrier, Sophie Clement, Yann Christinat, Jean-Christophe Tille, Mauro Frigeri, Krisztian Homicsko, Olivier Michielin, Alexandre Bodmer, Pierre O. Chappuis, Thomas A. McKee, Petros Tsantoulis
Published 2021-08-01